Table 1.
Parameter | Inclusion criteria | Exclusion criteria |
---|---|---|
Population | Patients with a diagnosis of BMS according to the International Classification of Headache Disorders-3 (ICHD-3) [29]: patients presenting symptoms of oral burning or pain lasting more than 2 h per day for more than 3 months | Any local or systemic factors that could produce the symptoms of oral burning pain, such as oral infections, oral lichen planus, or oral candidiasis |
Intervention | LLLT (600–1100 nm) was delivered directly to the site of pain; no limitations were placed on exposure duration or distance | |
Comparator | No treatment or other treatments | |
Outcomes |
Primary outcome: 1) Burning pain, measured using the Visual Analog Scale (VAS) Secondary outcomes: 1) Oral health-related quality of life, assessed by the Oral Health Impact Profile-14 (OHIP-14); 2) Negative emotions, measured using the Hospital Anxiety and Depression Scale (HADS); 3) Other relevant outcomes and serious adverse events |
|
Study design |
1) Randomized controlled trials; 2) Published in English |
1) Observational studies; 2) Non-randomized controlled trials; 3) Other types of studies |